Whilst use of exogenous surfactant has spread worldwide during the last 5 to 10 years, information from the developing world in 1995 shows that it may have a different impact there than in the developed world. Higher neonatal mortality and limited human and equipment resources may preclude the extrapolation of results of randomized clinical trials performed in developed countries.